Shire says willing to recommend Takeda's $64 billion offer to shareholders

Rare disease drug maker Shire said it was willing to recommend a sweetened offer from Japan's Takeda to shareholders.

from Mergers and Acquisitions https://ift.tt/2vHb8uJ